Skip to main content

OECHSLER

ApplicationAnsbach, Germany· One of 686 Application companies tracked by AMPulse

A global manufacturing partner specializing in polymer technology and high-volume additive manufacturing for various industries.

CEO / Founder
Karl Ostler (appointed Spokesman of Executive Board January 2024, Chairman/CEO January 2025)
Team Size
1001-5000
Stage
Active
Total Funding
$30.56M
Latest Round
Private Equity
Key Investors
Deutsche Beteiligungs AG (DBAG); DBAG Expansion Capital Fund

Technology & Products

Key Products

Injection-moulded precision plastic parts, electromechanical components, actuators, components for vacuum pumps, sporting goods, plastic metal systems, powder injection molding, and medical devices under OECHSLERhealth brand.

Technological Advantage

The company's core advantage is its proven capability for series production in additive manufacturing, allowing it to serve high-volume clients like Adidas for consumer products. This is supported by deep expertise in materials science, process development, and quality assurance.

Patent position

OECHSLER filed 38 patent families across all years; Materials accounted for 89% of families filed in 2022-2024, while CN accounted for 92% of all families. AMPulse analysis

Filing momentum
14 families filed 2022–2024, 23 in 2019–2021
Focus, 2019–2021 → 2022–2024
Materials 87% → 89%
Filed in
CN 92%EP 8%US 8%

38 AM patent families in total. Recent years are still being published, so read a filing change against the same-office figure.

Differentiation

Value Proposition

OECHSLER delivers innovative, high-tech solutions in polymer processing and additive manufacturing, enabling the mass production of complex components with certified, high-quality standards, backed by over 150 years of manufacturing expertise.

How They Differentiate

OECHSLER differentiates through its long-standing history and deep expertise in polymer science, which it leverages for its advanced additive manufacturing services. Unlike many competitors, it has a proven track record of high-volume AM production for consumer-facing products.

Market & Competition

Target Customers

Companies in the automotive, medical, and consumer goods (especially sporting goods) industries requiring high-volume, high-precision polymer parts and additive manufacturing solutions.

Industry Verticals

Automotive, Healthcare, Sporting Goods, Industrial

Competitors

Nemera, PlastFormance, Novares

Growth & Milestones

Growth Metrics

The company has been consistently expanding its global footprint and investing heavily in its additive manufacturing and medical technology divisions. It has publicly reported sales figures, showing resilience and growth in key strategic areas.

Major Milestones

Founded in 1864, achieving over 150 years in business., Establishing one of the world's largest polymer-based additive manufacturing facilities for series production., Long-term partnership with Adidas for the mass production of 3D printed footwear components., Successful expansion into the healthcare and medical device manufacturing sector under the OECHSLERhealth brand.

Notable Customers

Mekra Lang, Kiekert

https://www.oechsler.com/en

Official records

Filings, certifications, and programme counts AMPulse can show for this company.

  • [C] ISO_13485 · claimed
  • [C] ISO_9001 · claimed
  • [C] ITAR · claimed
  • [F] Horizon / CORDIS · 1 AM awardProject records derived from CORDIS, the European Union research results portal, CC BY 4.0.
  • [F] Waste-Based Rapid Adhesive-free Production of Sports goods · 2015

AM patents

AM-relevant patents linked to this company.

Patents
41
Granted
6
Families
38

Leading domains: process (40), material (22), software (4)

Filings by year: 2026: 1 · 2024: 9 · 2023: 1 · 2022: 5 · 2021: 17 · 2020: 8

  1. METHOD FOR SMOOTHING A SURFACE OF A BODY PRODUCED IN AN ADDITIVE PRODUCTION METHOD AND BODY PRODUCED IN AN ADDITIVE PRODUCTION METHOD04215348 · EP
  2. Method for 3D printing of single and composite photoresponse type plastic parts and application of 3D printing of single and composite photoresponse type plastic parts119748851 · CN
  3. Composite thermal conductive material and preparation method thereof112500699 · CN
  4. a vest113303526 · CN
  5. METHOD FOR CELL-COMPLIANT SPLITTING OF A GRID STRUCTURE04082790 · EP

Funding rounds

  • Private Equity$30.56M2015-02Source: DBAG Press Release - February 2015

Why this company matters

AMPulse analysis, not a company disclosure

OECHSLER is a global polymer technology group based in Ansbach, Germany, that bridges traditional injection molding with high-volume additive manufacturing. Founded in 1864, the company operates three business units—Mobility, Innovative Solutions, and Health—and is undergoing a transformation program called BE:FOCUSED to streamline operations toward profitable growth.

The company's core technology is polymer additive manufacturing, deployed at industrial scale for series production. Its facility is among the largest of its kind globally, enabling the mass production of complex polymer components. OECHSLER also produces injection-molded precision parts, electromechanical components, actuators, and medical devices under the OECHSLERhealth brand.

OECHSLER serves automotive, healthcare, sporting goods, and industrial customers. Its most visible application is the mass production of 3D-printed footwear components for Adidas, a long-term partnership that demonstrates its capability for high-volume consumer goods. Other named customers include Mekra Lang and Kiekert. The company's technological advantage lies in its materials science expertise, process development, and certified quality assurance for series AM production.

OECHSLER differentiates from competitors like Nemera, PlastFormance, and Novares through its proven track record in high-volume AM for consumer products, backed by deep polymer science heritage. Key partnerships with Carbon and HP support its additive capabilities. The company has raised approximately $30.56 million from investors including Deutsche Beteiligungs AG and DBAG Expansion Capital Fund.